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Dendritic cells (DCs) play a pivotal role in controlling
the balance between tolerance and immunity in
the intestine. Gut conditioned CD103+ DCs promote
regulatory T (Treg) cell responses; however, little is
known about DCs that drive inflammation in the
intestine. Here, we show that monocyte-derived
inflammatory DCs that express E-cadherin, the
receptor for CD103, promote intestinal inflammation.
E-cadherin+ DCs accumulated in the inflamed mes-
enteric lymph nodes and colon, had high expression
of toll-like receptors, and produced colitogenic
cytokines, such as IL-6 and IL-23, after activation.
Importantly, adoptive transfer of E-cadherin+ DCs
into T cell-restored immunodeficient hosts increased
Th17 cell responses in the intestine and led to exac-
erbation of colitis. These results identify a monocyte-
derived inflammatory DC subset that is associated
with the pathogenesis of intestinal inflammation,
providing a therapeutic target for the treatment of
inflammatory bowel disease.
INTRODUCTION
The intestine is a unique microenvironment that must constantly
maintain a delicate balance between effector and tolerogenic
T cell responses because inadequate protective immunity may
result in opportunistic infections, whereas aberrant reactions
against the commensal flora may trigger chronic intestinal
pathologies, such as inflammatory bowel disease (IBD) (Xavier
and Podolsky, 2007).
Dendritic cells (DCs) are specialized antigen-presenting cells
that play a pivotal role in shaping the host’s immune response
(Steinman et al., 2003). Several types of DCs have been
described according to their origin, location, receptor expres-
sion, and functional characteristics. Secondary lymphoid organs
contain both conventional resident and migratory DCs, but the
relative functional contribution of these subsets in controlling
tissue immunity is poorly understood (Geissmann et al., 2008).
In addition,monocyte-derived DCs accumulate in infected tissuesites where they promote protective innate and adaptive
responses (Leo´n et al., 2007; Nakano et al., 2009; Salazar-
Gonzalez et al., 2006; Serbina et al., 2003).
Alterations in intestinal DCs are thought to contribute to the
effector pathways that lead to IBD. Both in human Crohn’s
patients and in murine colitis models, pathology is associated
with the local accumulation of activated DCs (Hart et al., 2005;
Uhlig et al., 2006b). In colitic mice, mesenteric lymph node
(MLN) DCs express elevated amounts of CD40 and CD134L,
and blockade of either the CD40-CD40L (Uhlig et al., 2006b) or
the CD134-CD134L (Malmstro¨m et al., 2001) pathway inhibits
colitis, illustrating that DCs promote colitogenic responses.
However, which particular DC subsets contribute to chronic
T cell-mediated colitis is not known.
Precisely how DCs within the same tissue can drive both
tolerance and immunity is poorly understood. One hypothesis
is that these distinct functions are performed by different DC
subsets, which may be segregated both temporally and spatially
within the tissue in order to maintain both homeostasis and
rapid protective responses upon demand. We and others have
previously identified a functionally distinct population of DCs that
are enriched within the gut-associated lymphoid tissue (GALT)
and which express the integrin a chain CD103 (aE) (Johansson-
Lindbom et al., 2005). In earlier studies, we found that regulatory
T (Treg) cells were unable to suppress colitis in hosts that
lacked CD103, indicating a functional role for CD103+ DCs in
maintaining gut homeostasis (Annacker et al., 2005). Further-
more CD103+, but not CD103, MLN DCs were able to promote
the differentiation of Treg cells, suggesting a role for this popula-
tion in the support of both conventional and antigen-induced
Treg cells in the GALT (Coombes et al., 2007; Sun et al., 2007).
Recent elegant studies have shown that the two major popula-
tions of CD11chi DCs in the intestine have distinct origins.
Thus, CD103+CX3CR1
DCs arise from the commonDCprogen-
itor (CDP) via a pre-DC intermediate, whereas CD103CX3CR1
+
DCs develop from Gr1hi monocytes (Bogunovic et al., 2009;
Varol et al., 2009). Developmental differences may therefore
account for the distinct functional features of CD103+ and
CD103 DC subsets in the GALT.
To date, only one ligand of CD103 has been identified, which is
E-cadherin (Cepek et al., 1994). E-cadherin is a single-span
transmembrane glycoprotein that, as well as binding to CD103,
also undergoes homotypic interactions that form the core
of intercellular tight junctions (Takeichi, 1991). Consequently,Immunity 32, 557–567, April 23, 2010 ª2010 Elsevier Inc. 557
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E-Cadherin+ Dendritic Cells Promote ColitisE-cadherin has a central role in the maintenance of tissue archi-
tecture and early embryonic development (Larue et al., 1994).
Although it is widely acknowledged that E-cadherin is a marker
of nonhematopoietic intestinal epithelial cells (IECs), E-cadherin
is also expressed by bonemarrow-derived DCs (BM-DCs) (Jiang
et al., 2007), keratinocytes (Tang et al., 1993), and Langerhans
cells (LCs) (Riedl et al., 2000). Recently, it has been demon-
strated that E-cadherin-stimulated DCs promote Treg cells and
that the E-cadherin-b-catenin signaling pathway may be
involved in the acquisition of an immunosuppressive DC pheno-
type in vitro (Jiang et al., 2007). The distribution and function of
E-cadherin+ DCs in vivo is not known.
Here, we have identified and characterized a population of
E-cadherin+ DCs that accumulates within the intestine and
GALT during T cell-mediated colitis. Our results suggest that
E-cadherin+ DCs represent an inflammatory monocyte-derived
DC population that can promote chronic pathological inflamma-
tory responses in the gut.
RESULTS
E-Cadherin Is Expressed by a Minor Population
of CD11chi DCs in Normal Mice
E-cadherin has been shown to be expressed primarily by nonhe-
matopoietic IECs, but there are exceptions, including LCs and
BM-DCs (Jiang et al., 2007; Riedl et al., 2000). We first analyzed
whether E-cadherin was expressed by DCs in secondary
lymphoid tissue. Tissues were harvested, and CD11c-enriched
cell suspensions were prepared and subject to flow cytometry
analysis. To focus on DCs, cells were gated on the high-forward
and side-scatter cell population, which removed the majority of
CD11c cells, and 7-AAD+ dead cells were excluded. E-cadherin
expression among the CD11chiMHC class IIhi population was
examined. This gating strategy was applied to all experiments
unless otherwise stated (Figure S1A available online). We found
that a minor population of CD11chi cells in the MLN, axillary LN
(ALN), and spleen of normal mice expressed E-cadherin (Fig-
ure S1B). E-cadherin+CD11chi cells from the MLN expressed
similarly high amounts of MHC class II, and the costimulatory
molecules CD80, CD86, and CD40 as the reciprocal E-cadher-
inCD11chi population, and, hence, displayed the phenotypic
characteristics of DCs (Figure S1C). E-cadherin+CD11chi cells
did not express Gr1, and they were heterogeneous for CD8a
and CD11b, indicative of a mixed DC population. The majority
of E-cadherin+ DCs at steady state also expressed CD103
(Figure S1D).
E-Cadherin+ DCs Accumulate during T Cell-Mediated,
but Not Innate, Colitis
We have previously shown that intestinal inflammation is charac-
terized by an accumulation of activated DCs within the GALT
(Malmstro¨m et al., 2001). However, very little is known about
the role of specific DC subsets in chronic T cell-mediated intes-
tinal inflammation. To further investigate this, we used the T cell
transfer model of colitis, where transfer of CD4+CD45RBhi T cells
to immunodeficient hosts leads to mucosal and systemic inflam-
mation. In this model, colitis was associated with a more than
10-fold increase in the frequency of E-cadherin+ DCs in the colon
and MLN compared to unreconstituted Rag2/ control mice558 Immunity 32, 557–567, April 23, 2010 ª2010 Elsevier Inc.(Figures 1B and 1C), and a more than 3-fold increase in the
frequency of E-cadherin+ DCs compared to WT mice (Fig-
ure S2A). Changes in frequency did not reflect the loss of another
subset because there were also large increases in the total
number of E-cadherin+ DCs in the inflamed MLN and colon
(Figure 1D). E-cadherin+ DCs in the MLN and colon may derive
from a blood precursor because E-cadherin+CD11cint cells
were present in the blood of colitic, but not normal, uninflamed
mice (Figure S2A). CD4+CD25+ Treg cells are known to inhibit
colitis and maintain intestinal homeostasis (Read et al., 2000)
(Figure 1A). In mice protected from colitis by Treg cells, there
was no accumulation of E-cadherin+ DCs above those found in
the GALT of unreconstituted Rag2/ mice (Figures 1C and
1D). Quantitative PCR (qPCR) analysis confirmed DC E-cadherin
expression at the mRNA level (Figure S2B).
To assess the role of T cell-derived signals in the accumulation
of E-cadherin+ DCs, we utilized an anti-CD40 model of innate
colitis. In this model, injection of an agonistic CD40 mAb leads
to focal colitis with a large accumulation of activated DCs in
the MLN and colon. We found that approximately 85% of MLN
and 50% of colonic DCs expressed E-cadherin (Figure 1E).
By contrast, despite a large systemic and intestinal inflammatory
response, Helicobacter hepaticus-induced innate colitis was not
associated with an increase in the frequency of E-cadherin+ DCs
in either the GALT or spleen (Figure 1F). Together, these data
indicate that the accumulation of E-cadherin+ DCs is linked to
T cells and that the provision of a CD40 signal alone is sufficient
to drive accumulation of E-cadherin+ DCs.
Phenotypic Characterization of E-Cadherin+ DCs
during Intestinal Inflammation
Phenotypic characterization showed that during colitis, the
majority of MLN and colon E-cadherin+ DCs were CD103
CD11b+CD8aGr1 (Figure 2A). Under inflammatory conditions,
E-cadherin+ DCs did not express CCR7 (Figures 2B and 2C),
suggesting that these cells may enter the MLN directly from
the blood (Jang et al., 2006).
E-Cadherin+ DCs Arise from Inflammatory
Gr1+ Monocytes
To investigate the lineage relationship of E-cadherin+ DCs to
other intestinal DC subsets, bromodeoxyuridine (BrdU)-labeling
studies were performed (Figure 3A). DCs were divided into
three subsets based on E-cadherin and CD103 expression:
E-cadherin+CD103; CD103+E-cadherin; and E-cadherin
CD103 double negative (DN) cells. Each of these subsets
showed rapid BrdU uptake, without any detectable lag in the
labeling kinetics, which indicated that the E-cadherin+ DCs
were not derived from either the CD103+E-cadherin or the DN
cell populations. Furthermore, the E-cadherin+ DCs showed
the fastest input of labeled cells, suggesting recent generation
from a dividing precursor. Indeed, we also found that approxi-
mately 20% of MLN E-cadherin+ DCs expressed Ki-67 (Fig-
ure 3B), indicating that this newly differentiated DC population
may undergo a limited number of cell divisions.
After emerging from the bone marrow (BM) Gr1+CCR2+
CX3CR1
loCD115+ monocytes home to sites of inflammation,
where they differentiate into inflammatory DCs (Geissmann
et al., 2003). We next determined whether E-cadherin+ DCs were
Figure 1. E-Cadherin+ DCs Accumulate
during T Cell-Mediated Colitis
(A–D) BALB/c Rag2/ mice were reconstituted
with 4 3 105 CD4+CD45RBhi T cells and were
sacrificed when displaying clinical signs of colitis.
Transfer of 2 3 105 CD4+CD25+ T cells in combi-
nation with the CD4+CD45RBhi T cells suppressed
both weight loss and disease (termed protected).
(A) Weight as a percentage of the initial weight at
day 0. Triangle, colitic mice; square, protected
mice; circle, non-T cell reconstituted Rag2/
mice. (B) Colon, MLN, spleen, and blood cell prep-
arations from colitic mice were gated on CD11c+
DCs, and expression of E-cadherin was assessed.
Representative staining is shown. Solid black line,
E-cadherin; dashed line, E-cadherin isotype
control. (C) Mean frequency and (D) cell number
of CD11c+ cells expressing E-cadherin isolated
from colitic colon, MLN, spleen, and blood. (E)
B6 Rag1/ mice were injected with either 200 mg
a-CD40 mAb or PBS, and after 7 days, colon,
MLN, and spleen cell preparations were prepared.
Mean frequency of CD11chi cells expressing
E-cadherin. (F) 129SvEv Rag2/ mice were
infected with H. hepaticus, and 8 weeks later,
colon, MLN, and spleen cell preparations were
prepared. Mean frequency of CD11c+ cells
expressing E-cadherin. Black bars, inflamed;
open bars, control; dark gray bars, protected.
Error bars represent SD. In all cases, the experi-
ments were repeated more than two times, with
each experimental group containing more than
five individual mice.
See also Figure S1.
Immunity
E-Cadherin+ Dendritic Cells Promote Colitismonocyte derived. We found that during both steady-state and
inflammatory conditions, the majority of Gr1+CD11b+CD115+
monocytes themselves expressed E-cadherin (Figure 3C).
A small population of Gr1CD11b+CD115+ cells was also E-cad-
herin+. To investigate whether these progenitor cells could give
rise to E-cadherin+ DCs, CD115+ BM monocytes were sorted
by flow cytometry into Gr1+ and Gr1 fractions and stimulated
overnight with GM-CSF. Gr1+ monocytes retained their expres-
sion of E-cadherin and upregulated CD11c to elicit a population
of E-cadherin+CD11c+ DCs (Figures 3D and 3E). Similar experi-
ments were also performed in the presence of Flt3L but neither of
the monocyte subsets differentiated into E-cadherin+CD11c+
cells (data not shown).
To determine whether Gr1+ monocytes also differentiated into
E-cadherin+ DCs in vivo, adoptive transfer experiments were
performed. Flow cytometry-sorted Gr1+ and Gr1 CD115+
CD11b+ckitCD11c BM monocytes from CD45.1 mice (Fig-
ure S3A) were injected i.v. into colitic CD45.2 recipients. After
36 hr, CD45.1 cells present in various tissues (Figure 3F) were
examined for their expression of E-cadherin and CD11c. Gr1+
monocytes differentiated into CD11chi cells in all tissues exam-
ined, and the vast majority of these expressed E-cadherin (Fig-
ure 3G). There was no evidence that E-cadherin+CD11c+ cells
in theMLNderived from the colon because therewas amoderate
increase in the proportion of CD45.1+Gr1+ monocyte-derivedCD11chi cells in the MLN compared to the colon (Figure S3B).
By contrast, Gr1 monocytes were significantly reduced in their
ability to generate E-cadherin+CD11chi cells (Figure 3G). These
data suggest that during colitis, Gr1+, and to some degree
Gr1, monocytes may independently home to sites of inflamma-
tion and differentiate into E-cadherin-expressing CD11chi cells.
TGF-b Limits the Accumulation of E-Cadherin+ DCs
It iswell established thatTGF-bplaysan important role in intestinal
homeostasis and has direct regulatory effects on DCs (Zhang
et al., 2004). In light of these findings, we examined the effect of
TGF-b treatment on in vitro-generated BM-DCs. We found that
the addition of TGF-b led to a profound downregulation of E-cad-
herin expressionby theBM-DCs (Figure4A). Furthermore, inTGF-
b-deficientmice, which do not display histological signs of colitis,
we found enhanced frequencies of E-cadherin+DCscompared to
littermate controls (Figures 4B and 4C). This increase was most
pronounced in the colon and small intestine (SI), indicating that
tissue-specific regulatory cytokines, such as TGF-b, may be
important for limiting the accumulation of E-cadherin+ DCs.
E-Cadherin+ DCs Display a Proinflammatory Gene
Expression Profile
To gain insight into the function of E-cadherin+ DCs, we per-
formed gene expression profiling by qPCR. We have previouslyImmunity 32, 557–567, April 23, 2010 ª2010 Elsevier Inc. 559
Figure 2. Phenotypic Characterization of
E-Cadherin+ DCs during Inflammation
(A) Staining of CD103, CD11b, CD8a, Gr1, and
E-cadherin gated on CD11chi DCs from MLN and
colon cells prepared from colitic BALB/c Rag2/
mice. Positioning of the quadrants reflects the
isotype control. Experiment was repeated more
than two times. In all cases, representative plots
from three to five individual analyses are shown.
(B and C) MLN cells were prepared from BALB/c
WT and colitic BALB/c Rag2/ mice. (B) Repre-
sentative staining of CCR7 and E-cadherin gated
on CD11chi DCs. (C) Mean percentage of E-cad-
herin+CD11chi cells expressing CCR7. Data are
representative of two independent experiments.
Error bars represent SD. (n = 4–6 mice per group).
See also Figure S2.
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E-Cadherin+ Dendritic Cells Promote Colitisshown that CD103 DCs produce inflammatory cytokines upon
activation (Coombes et al., 2007); however, in these studies,
E-cadherin expression among the DCs was not considered.
Subsequently, for the following experiments, E-cadherin
CD103 DCs were chosen as the reference population with
which comparisons were made. We found that E-cadherin+
CD11chiCD1037-AADCD4 DCs expressed more than 5-fold
higher amounts of various toll-like receptors mRNA than
E-cadherin counterparts (Figure 5A), but E-cadherin+ DCs did
not express Tgfb2, Plat, or Aldh1a2, which are genes associated
with a tolerogenic DC signature (Figure 5B). It is now well estab-
lished that CCR2 is required for the recruitment of monocytes
into inflamed tissues (Dunay et al., 2008) and that CCR6 expres-
sion marks a subset of inflammatory DCs within the SI (Salazar-
Gonzalez et al., 2006). We found that E-cadherin+ DCs
expressed approximately 30-fold higher amounts of Ccr2 and
3,000-fold higher amounts of Ccr6 mRNA than E-cadherin
DCs, and flow cytometry analysis confirmed that E-cadherin+
DCs were indeed the main expressers of CCR6 in the MLN
(Figures 5C and 5D). These data suggest that E-cadherin+ DCs
may be hyper-responsive to microbial stimulation, reinforcing
their inflammatory potential.
Functional Characterization of E-Cadherin+ DCs
To confirm that MLN E-cadherin+CD11chi cells from colitic mice
displayed characteristics associated with DCs, we investigated
their phenotypic and functional properties. E-cadherin+CD11chi
cells expressed high amounts of MHC class II, CD80, and CD40,
but moderate amounts of CD86, compared with E-cadherin560 Immunity 32, 557–567, April 23, 2010 ª2010 Elsevier Inc.counterparts (Figure S4A). A cardinal
feature of DCs is their capacity to process
antigen and prime naive T lymphocytes
(Banchereau et al., 2000). We thus com-
pared the ability of MLN E-cadherin+
and E-cadherinCD11chiCD1037-AAD
CD4 cells that were pulsed with OVA
protein to activate splenic CFSE-labeled
CD4+ T cells isolated from DO11.10
SCID mice. Antigen stimulation by
both DC populations led to increasedT cell activation, as assessed by cell division, compared with
myeloid MHC class II+CD11cF4/80+ control cells (Figure S4B).
Importantly, E-cadherin+ DCs also supported higher CD4+
T cell accumulation than E-cadherin DCs or myeloid control
cells (Figure S4C). Together, these data show that E-cadher-
in+CD11chi cells from the MLN are capable of antigen uptake,
processing, and presentation, leading to the antigen-induced
activation and accumulation of naive T cells. Based on these
criteria, E-cadherin+CD11chiMLN cells bear the hallmark features
of DCs.
E-Cadherin+ DCs Produce Colitogenic Cytokines
upon Activation
To further investigate the function of this DC population,
E-cadherin+ and E-cadherin CD11chiCD1037-AADCD4
DCs from the MLN of colitic mice were stimulated overnight
with LPS or an agonistic CD40 mAb, and cytokine production
was examined. Even in the absence of further stimulation,
E-cadherin+, but not E-cadherin, DCs produced high amounts
of proinflammatory cytokines and chemokines, which could
be enhanced by the addition of either anti-CD40 or LPS
(Figure 6A). By qPCR, we also found that upon stimulation
through CD40, E-cadherin+ DCs expressed more than 100-fold
higher amounts of IL-23p19 and IL-12p40 mRNA than
E-cadherin DCs, with only a comparatively moderate increase
in the expression of IL-12p35 (Figure 6B). These data suggest
that E-cadherin+ DCs may function as effector leukocytes
in vivo, involved in proinflammatory cytokines and chemokines
upon activation.
Figure 3. Gr1+ Monocytes Differentiate into
E-Cadherin+ DCs
(A) Colitic BALB/c Rag2/mice were injected i.p.
with 2 mg of BrdU. At various time points, whole
colon cells were stained for E-cadherin, CD103
and CD11c surface markers, and for intracellular
BrdU. Cells were gated on the CD11chi population
and then examined for the percentage of BrdU+
cells among each DC subset. Each symbol repre-
sents three mice assayed at each time point.
(B) Representative staining of E-cadherin, Ki-67,
and the relevant isotype control of Ki-67 on gated
CD11chi cells from MLN cell preparations from
colitic mice (n = 4).
(C) Expression of E-cadherin by CD115+Gr1+
and Gr1 monocytes taken from BM of WT and
colitic Rag2/ mice. Gates applied shown on
left panel. Black solid line, E-cadherin expression
by Gr1+CD115+ cells; gray solid line, E-cadherin
expression by Gr1CD115+ cells; dashed line,
E-cadherin expression by Gr1+CD115 control
cells. Representative plots from three to five indi-
vidual analyses are shown.
(D) Representative staining of E-cadherin and
CD11c on flow cytometry-sorted Gr1+ and Gr1
CD115+ monocytes from pooled BM of colitic
BALB/c Rag2/ mice (n = 8).
(E) The sorted monocytes were cultured overnight
in media with or without GM-CSF, and the next
day, the cells were harvested and analyzed for
E-cadherin and CD11c expression.
(F and G) 3 3 106 sorted Gr1+ or Gr1
CD11b+ckitCD11cCD115+ monocytes from
pooled BM and blood of naive B6 CD45.1 mice
were injected i.v. into colitic B6 CD45.2 Rag1/
mice, and 36 hr later, various tissues were har-
vested. Cells were gated on the CD45.1 popula-
tion, and E-cadherin expression among the
CD45.1+CD11chi cells was examined. Cells from
nontransferred control mice were isolated in
parallel. (F) Representative CD45.1 staining on
MLN cells. (G) Staining of E-cadherin and CD11c
gated on CD45.1+ cells from colitic mice that
received Gr1+(top panel) or Gr1 (bottom panel)
CD115+ monocytes (n = 3 per group). Numbers
represent mean ± SD of CD11chi cells expressing
E-cadherin. Representative data from one of
three experiments; similar experiments gave the
same results.
See also Figure S3.
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E-Cadherin+ Dendritic Cells Promote ColitisE-Cadherin+ DCs Exacerbate T Cell-Mediated Colitis
To assess the functional relevance of E-cadherin+ DCs in vivo,
we examined the effect of their administration on the progression
of T cell-mediated colitis. As GM-CSF promoted the generation
of E-cadherin+ BM-DCs (Figure S5A), which are generally
considered to represent an immature DC population (Inaba
et al., 1992a), we postulated that these cells may be more effec-
tive than ex vivo-derived DCs at migrating to the intestine. This
system also allows the generation of high DC yields, which areotherwise a limiting factor. Furthermore, E-cadherin+ BM-DCs
and MLN DCs share many similar phenotypic characteristics,
including high MHC class II and costimulatory molecule expres-
sion, and the majority of both E-cadherin+ BM-DCs and MLN
DCs are CD103, CD8a, and CD11b+ (Figures S5B–S5D).
Consequently, flow cytometry-sorted BM-derived E-cadherin+
and E-cadherin CD11chi cells (Figure 7A) were injected i.p
into B6 Rag1/ mice that had received naive CD4+CD45RBhi
T cells 2 weeks earlier. The intestinal inflammatory responseImmunity 32, 557–567, April 23, 2010 ª2010 Elsevier Inc. 561
Figure 4. TGF-b Limits the Accumulation of
E-Cadherin+ DCs
(A) Day 8 BM-DCs cultured with GM-CSF in the
absence (solid black line) or presence (solid gray
line) of TGF-b were stained for E-cadherin and
CD11c. Histogram shows representative staining
of E-cadherin on CD11chi gated cells. Dashed
line represents the isotype control.
(B) Representative staining of E-cadherin on
CD11chi gated cells taken from DO11.10 Tgfb1/
mice (black line) and littermate controls (gray line).
Dashed line represents the isotype control.
(C) Mean percentages of CD11chi cells expressing
E-cadherin from the small intestine, colon, MLN,
and spleen of DO11.10 Tgfb1/ mice (filled
bars, n = 3) and littermate controls (open bars,
n = 4). Error bars represent SD. Representative
data from one of three independent experiments.
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E-cadherin+, but not E-cadherin, BM-DCs displayed a signifi-
cant increase in total cell numbers in the colon and GALT
(Figure 7B) and developed more severe intestinal pathology
than control groups (Figure 7C). This was associated with severe
inflammation of the caecum and the development of crypt
abscesses and submucosal colonic inflammation, the latter of
which are parameters of severe colitis (Figure 7D).
We investigated the effect of BM-DC transfer on the T lym-
phocyte compartment of the GALT. Both E-cadherin+ and
E-cadherin BM-DCs failed to promote enhanced frequencies
of IFN-g+CD4+ T cells and no differences were observed in the
frequency of Treg cells (data not shown). However, recipients
of E-cadherin+, but not E-cadherin, BM-DCs displayed sig-
nificantly higher frequencies of IL-17+CD4+ T cells both in the
intestine and GALT (Figure 7E). Furthermore, due to the overall
increase in total cell numbers, E-cadherin+, but not E-cadherin,
BM-DCs also generated enhanced numbers of IL-17+ and IFN-
g+CD4+ T cells (data not shown). Taken together, these results
strongly suggest that E-cadherin marks a subset of physiologi-
cally relevant inflammatory DCs that are able to exacerbate
T cell-mediated colitis.
DISCUSSION
Here, we showed that the ligand for CD103, E-cadherin, marks
a population of CD11chi cells that accumulates in the GALT
and colon of colitic mice. E-cadherin+ DCs can derive from
Gr1+ inflammatory monocytes, they express an array of TLRs,
and upon activation, they produce high amounts of proinflam-
matory effector cytokines. Furthermore, transfer of E-cadherin+
DCs to immunodeficient mice exacerbates T cell-drivenmucosal562 Immunity 32, 557–567, April 23, 2010 ª2010 Elsevier Inc.immune pathology. These results newly
identify E-cadherin as a marker of mono-
cyte-derived inflammatory DCs that may
contribute to the pathogenesis of chronic
T cell-mediated colitis.
Tissues contain distinct DC subsets
that vary from one another according
to ontogeny, receptor expression, andtemporal separation in order to carry out distinct functions
(Merad and Manz, 2009). This division of labor between tissue
resident and inflammatory DCs may provide a mechanism by
which tolerogenic and effector responses can be accommo-
dated. DCs with an inflammatory phenotype accumulate in
response to infection. Thus, TNF and iNOS-producing (Tip)
DCs were shown to produce nitric oxide and TNF-a in response
to Listeria and Toxoplasma infection (Serbina et al., 2003).
In addition, CCR6+ DCs are rapidly recruited within the follicle-
associated epithelium of the SI Peyer’s Patches after oral Salmo-
nella infection (Salazar-Gonzalez et al., 2006). Monocytes are the
major precursors of inflammatory DCs (Geissmann et al., 2003).
Gr1+CCR2+CX3CR1
lo monocytes emigrate from the BM in
response to infection and home to sites of inflammation, where
they are able to differentiate into DCs (Serbina and Pamer,
2006). Blood-derived Gr1+ inflammatory DCs alsomediate acute
Th1 responses to viral infections in vivo (Nakano et al., 2009).
Here, we showed that E-cadherin+ DCs share several pheno-
typic and functional properties with these previously described
inflammatory DC populations.
The two main DC subsets present in the intestinal lamina
propria derive from distinct cell lineages, which may account
for their diverse functional properties. CD103+CX3CR1 DCs
develop from pre-DCs, whereas Gr1+ monocytes, under the
control of macrophage-colony stimulating factor (M-CSF) and
to a lesser extent Flt3L, give rise to CD103CD11b+CX3CR1
+
LP DCs (Bogunovic et al., 2009; Varol et al., 2009). We and
others have shown that CD103+ DCs promote the generation
of Treg cells (Coombes et al., 2007; Sun et al., 2007); however,
much less is known about the function of the reciprocal CD103
DC population (Fortin et al., 2009). Varol et al. (2009) showed
that monocyte-derived CD103CX3CR1
+ DCs are sufficient to
Figure 5. E-Cadherin+ DCs Display a Proin-
flammatory Gene Expression Profile
E-cadherin+ and E-cadherin CD11chiCD4
7AADCD103 cells were flow cytometry-sorted
from pooled MLN cell preparations taken from
colitic BALB/c Rag2/ mice (n = 10). (A) Tlr, (B)
Tgfb2, Plat, and Aldh1a2, and (C) Ccr2 and Ccr6
gene expression was assayed in triplicate by
qPCR, and each sample was normalized relative
to HPRT expression. Error bars represent SEM of
triplicate samples. (D) Ccr6 gene expression was
confirmed by flow cytometry analysis on MLN
cells taken from colitic BALB/c Rag2/ mice.
Data show representative E-cadherin and CCR6
staining on CD11chi gated cells. Data are repre-
sentative from one of three independent experi-
ments.
See also Figure S4.
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E-Cadherin+ Dendritic Cells Promote Colitisreconstitute acute colitis in DC-depleted mice. Several lines of
evidence suggest that Gr1+ monocytes are also the predomi-
nant precursor of inflammatory E-cadherin+ DCs. First, BrdU
labeling studies showed that E-cadherin+ DCs are not derived
from either CD103+ or CD103E-cadherin DC subsets. A large
proportion of E-cadherin+ DCs incorporated BrdU over 12 hr,
and approximately 20% of these cells proliferated in situ, sug-
gesting their recent derivation from a proliferating precursor.
This is likely to be an inflammatory blood monocyte as Gr1+,
and to a lesser extent Gr1, monocytes expressed E-cadherin.
Second, adoptively transferred Gr1+ monocytes migrated to
sites of inflammation and gave rise to E-cadherin+ DCs within
48 hr. Gr1+ monocytes preferentially accumulated in the MLN
over the colon, which suggests that circulating monocytes
may independently seed both of these sites, giving rise to
E-cadherin+CD11chi cells. In support of this, under inflammatory
conditions, the majority of MLN E-cadherin+ DCs did not
express CCR7, suggesting they are not a migratory population.
By contrast, they did express high CCR2 and CCR6. CCR2 has
previously been implicated in the egression of monocytes from
the BM (Serbina and Pamer, 2006), whereas CCR6 is required
for the localization of monocyte-derived DCs within the SI PPs
(Cook et al., 2000).Immunity 32, 557–5In the noninflamed intestine, E-cad-
herin+ DCs represent only a minor popu-
lation of the total DC compartment. In
colitic mice, they dramatically increase
in frequency, making up to 50% of
CD11chi cells in the colon and MLN.
These cells are likely to contribute to
disease pathogenesis as adoptive trans-
fer of in vitro generated E-cadherin+
DCs into T cell-restored immunodeficient
hosts led to an increased Th17 cell
response and enhanced colitis. E-cad-
herin+ DCs express a number of features
that may contribute to their pathogenic
action in the gut. They express high
amounts of a number of TLRs, making
them poised to respond to microbial trig-gers. Upon activation, E-cadherin+ DCs produce large quantities
of proinflammatory cytokines, such as IL-6, TNF-a, and IL-23
p19, that have previously been implicated in the pathogenesis
of IBD (Hue et al., 2006; Uhlig et al., 2006b). Even in the absence
of further stimulation, E-cadherin+ DCs produce considerable
amounts of proinflammatory chemokines, such as MCP-1 and
RANTES. In the intestine or MLN, E-cadherin+ DCs may there-
fore function as cytokine-chemokine reservoirs, which upon acti-
vation, release their cargo and, in doing so, rapidly create
chemotactic gradients that could serve to recruit effector mono-
cytes, neutrophils, and T cells to the site of inflammation and,
hence, propagate the immune cascade. Furthermore, E-cad-
herin+ DCs are capable of activating naive T cells and may
directly promote Th17 cells in the MLN through their production
of IL-23 and IL-6. As E-cadherin+ DCs represent a recently
recruited monocyte-derived DC population, they may escape
gut conditioning, endowing them with the capacity to override
the suppressive gut environment and, hence, stimulate inflam-
matory responses.
Although E-cadherin+ monocytes are present in the steady-
state BM, the accumulation of E-cadherin+ DCs in the colon
and GALT is a feature of T cell-mediated, but not bacteria-
induced, innate colitis. Colitogenic T cells express high levels of67, April 23, 2010 ª2010 Elsevier Inc. 563
Figure 6. E-Cadherin+ DCs Produce Proin-
flammatory Cytokines and Chemokines
E-cadherin+ and E-cadherin CD11chiCD1037-
AADCD4 DCs were sorted from pooled
MLN cell preparations taken from colitic BALB/c
Rag2/ mice (n = 10). The DCs were cultured in
triplicate overnight in media alone or in the pres-
ence of 10 mg/ml anti-CD40 or 1 mg/ml LPS.
(A) Supernatants were harvested, and cytokine
and chemokine concentrations were analyzed by
FlowCytomix immunoassays (open bars, no addi-
tions; gray bars, anti-CD40; black bars, LPS).
(B) Il23a (Il-23p19), Il12b (Il-12 and Il-23 p40), and
Il12a (Il-12p35) gene expression was assayed by
qPCR, and each sample was normalized relative
to HPRT expression (black bars, E-cadherin+
DCs; gray bars, E-cadherin DCs). Error bars
represent SEM of triplicate samples. Data are
representative from one of three independent
experiments.
Immunity
E-Cadherin+ Dendritic Cells Promote ColitisCD40L and disruption of CD40-CD40L interactions inhibits T cell
transfer colitis (De Jong et al., 2000). E-cadherin+ DCs express
high amounts of CD40, and addition of an agonistic CD40 mAb
is sufficient to induce colitis in B6 Rag1/mice, which is associ-
ated with the marked accumulation of E-cadherin+ DCs in the
intestine and MLN. These results suggest that CD40 signaling
in the absence of further T cell-derived signals is sufficient to
lead to the recruitment and differentiation of inflammatory mono-
cytes into E-cadherin+ DCs, and it raises the possibility that E-
cadherin+ DCs play a key role in driving anti-CD40-mediated
colitis. In the T cell transfer model of colitis, CD40L+ T cells may
act in a positive feedback loop to amplify the accumulation and
activation of E-cadherin+ inflammatory DCs. In addition, acti-
vated T cells may provide growth factors, such as GM-CSF or
M-CSF, which could drive the development of E-cadherin+ DCs.
Signaling through E-cadherin expressed on in vitro-generated
LCs inhibits DC maturation and, subsequently, proinflammatory
cytokine production (Riedl et al., 2000). More recently, it has
been shown that disruption of E-cadherin-mediated DC clus-
tering generates tolerogenic DCs, a process dependent on the
downstream signaling molecule b-catenin (Jiang et al., 2007).
The expression of E-cadherin on inflammatory monocytes and
monocyte-derived DCs may therefore provide a negative feed-
back loop to control inflammation-induced DC maturation in
tissues. Intestinal Treg cells and tolerogenic DCs in the intestine
express CD103, making it tempting to speculate that CD103-
E-cadherin interactions may contribute to Treg cell mediated
immune suppression. Indeed, because E-cadherin+ DCs fail to
accumulate in the steady state and during Treg cell-mediated
suppression of colitis, Treg cells may control the accumulation
of inflammatory E-cadherin+ DCs from monocyte precursors.
Notably, Treg cells were unable to prevent T cell mediated colitis
in CD103-deficient recipients, suggesting a functional role for564 Immunity 32, 557–567, April 23, 2010 ª2010 Elsevier Inc.m
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immune homeostasis (Annacker et al.,
2005).
Little is known about the factors that
control E-cadherin expression on inflam-atory DCs. IL-1b and TNF-a downregulate E-cadherin expres-
ion on human monocyte-derived LCs, however the in vivo
levance of this was not established (Jakob and Udey, 1998).
s observed in neoplastic cells (Fransvea et al., 2008), we found
at TGF-b downregulates E-cadherin expression on BM-DCs
ultured with GM-CSF. TGF-b also controls the accumulation
f E-cadherin+ DCs in vivo as DO11.10 Tgfb1/mice exhibited
creased frequencies of E-cadherin+ DCs in the intestine. Simi-
rly, IL-10 prevents intestinal inflammation through effects on
yeloid cells (Takeda et al., 1999) and has also been shown to
mit TipDC-mediated pathogenicity (Guilliams et al., 2009).
oth TGF-b and IL-10 are important components of the immune
uppressive network in the gut, and control of the generation
r recruitment of inflammatory DCs may contribute to their
nction.
In summary, we have identified E-cadherin as a marker of a
ubset of inflammatory monocyte-derived DCs that contribute
chronic T cell-mediated intestinal inflammation. Further
nderstanding of the factors that control the migration and
nction of these cells may provide novel therapeutic strategies
IBD.
XPERIMENTAL PROCEDURES
ice
ALB/c, BALB/c Rag2/, DO11.10 Tgfb1/, C57BL/6 (B6) WT, B6 CD45.1,
6 Rag1/, 129SvEv Rag2/ and DO11.10 SCID TCR-transgenic mice were
red and maintained under specific pathogen-free conditions in an accredited
nimal facility at the University of Oxford. All procedures involving animals
ere conducted according to the requirements and with the approval of the
nited Kingdom Home Office Animals (Scientific Procedures) Acts, 1986.
ntibodies
he following antibodies were used for CD4+ T cell purification: anti-mouse
D8 (YTS169), -MHC class II (TIB120), -Mac-1 (M1/70), and -B220 (RA3-6B2,
Figure 7. Adoptive Transfer of E-Cadherin+
BM-DCs Exacerbates T Cell-Mediated
Colitis
(A–E) BM-DCs were generated in the presence of
GM-CSF. At day 8 of culture, cells were harvested,
E-cadherin+ and E-cadherin BM-DCs were
sorted, and 3 3 106 cells were i.p. injected into B6
Rag1/ mice that had received CD4+CD45RBhi
T cells 14 days earlier. Ten days post-DC transfer,
the mice were sacrificed and examined for exacer-
bated colitis compared to non-DC transferred
controls. (A) Gating strategy applied to sorting
E-cadherin+ and E-cadherin BM-DCs. (B) Total
cell numbers of small intestine, colon, MLN, and
spleen preparations. (C) Colon histology scores.
(D) Representative photomicrographs of hematox-
ylin and eosin-stained sections of colon (top panel)
and caecum (bottom panel). (E) Mean percentages
of CD4+ T cells expressing IL-17 in the small
intestine, colon, MLN, and spleen. Open bars,
CD45RBhi T cells; gray bars, CD45RBhi T cells and
E-cadherin BM-DCs; black bars, CD45RBhi
T cells and E-cadherin+ BM-DCs. Error bars repre-
sent SD. Data shown are representative of one
out of three independent experiments.
See also Figure S5.
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E-Cadherin+ Dendritic Cells Promote Colitisall purified from hybridoma supernatant by affinity chromatography). The fol-
lowing anti-mouse monoclonal antibodies were used for multiparameter
FACS analyses: CD45RB (16A), CD25 (PC61), CD80 (16-10A1), CD86 (GL1),
CD40 (3/23), CD11b (M1/70), CD8a (53-6.7), CCR7 (4B12), CCR6 (140706),
CD11c (HL3), CD103 (M290), CD4 (GK1.5/RM4-5), 7-AAD, CD3e (145-2C11),
CD115 (AF598), E-cadherin (36), Gr-1 (RB6-8C5), I-Ab (2G9), and Ki-67 (B56).
The corresponding isotype controls and the secondary reagent allophycocya-
nin-Cy7-conjugated streptavidin were all purchased from BD Biosciences.
For use in both in vivo and in vitro cultures, anti-mouse CD40 (FGK45) were
purified from hybridoma supernatant by affinity chromatography and shown
to contain <0.1 EU endotoxin per milligram of protein.
Preparation and Culture of CD11chi Subsets
Spleen and lymph nodes were digested with collagenase type VIII (Sigma-
Aldrich) as previously described (Coombes et al., 2007). CD11c+ cells were
then positively selected on an LS MACS column (Miltenyi Biotec). MLN cell
suspensions from colitic mice were not CD11c-enriched because of the local
accumulation of DCs during inflammation. Cell suspensions were prepared
from the colon and SI LP as previously described (Sun et al., 2007; Uhlig
et al., 2006a). For FACS analysis, we first gated on the high forward and side
scatter cells in order to remove themajority of CD11c cells, 7-AAD+ dead cells
were excluded, and E-cadherin expression among the CD11chi cells was
examined. For cell sorting, cellswere purified into E-cadherin+ andE-cadherin
CD11chiCD103CD47-AAD fractions (>98%) on a MoFlo sorter (Dako cyto-
mation). For analysis of cytokine production, DC subsets were cultured over-Immunity 32, 557–5night in DMEM supplemented with 10% FCS,
2 mM L-glutamine, and 100 U of penicillin and
streptomycin. LPS (1 mg/ml, Sigma-Aldrich) or
anti-CD40 (10 mg/ml) were added to some wells.
Supernatants were analyzed for chemokine and
cytokine production using a FlowCytomix immu-
noassay (Bender MedSystems), according to the
manufacturer’s instructions. Cells were prepared
for qPCR analysis, as described below.
T Cell Transfer Model of Colitis
Naive CD4+CD25CD45RBhi T cells were isolated
fromB6orBALB/cWTmiceandwereFACSsortedas previously described (Readet al., 2000). Sex-matchedB6Rag1/or BALB/
cRag2/ recipients were i.p. injected with 43 105 cells, and the development
of intestinal inflammation was monitored. Mice were killed >6 weeks after
cell transfer, and tissues were collected for cell populations or histological
analysis. For some experiments, CD4+CD25+CD45RBlo T cells were sorted
and cotransferred with the naive T population at 2 3 105 cells per mouse.
Anti-CD40 Model of Colitis
B6 Rag1/mice were i.p. injected with 200 mg FGK45 CD40 mAb. Mice were
weighed daily and killed at day 7.
Helicobacter hepaticus Induced Model of Colitis
129SvEv Rag2/mice were inoculated intragastrically with 0.3 ml of aHelico-
bacter hepaticus suspension (NCI-Frederick isolate 1A) prepared to a McFar-
land turbidity standard of 1.0 in PBS representing 2.45 3 109 CFU/ml. Three
doses were administered on days 0, 2, and 4, and mice were killed 6 weeks
later.
Assessment of Pathology
Mice were killed when clinical symptoms of intestinal inflammation (diarrhea
and weight loss) became apparent, usually >6 weeks after initiation of an
experiment. Samples of distal, mid-, and proximal colon were immediately
fixed in buffered 10% formalin. Paraffin embedded 5 mmsections were stained
with hematoxylin and eosin, and inflammationwas assessed using a previously
described scoring system (Izcue et al., 2008).67, April 23, 2010 ª2010 Elsevier Inc. 565
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BALB/c Rag2/ mice were transferred with CD4+CD45RBhi T cells and after
6 weeks, when the recipients displayed clinical signs of intestinal inflammation,
the mice were i.p. injected with 2 mg BrdU (Sigma-Aldrich) resuspended in
PBS. Cell suspensions were prepared at different time points after BrdU
administration and were analyzed for BrdU incorporation with the BrdU Flow
Kit (BD Biosciences) according to the manufacturer’s instructions.
Culture and Transfer of Monocytes
BM and whole blood cell suspensions were isolated from B6 and BALB/c WT
or colitic B6 Rag1/ and BALB/c Rag2/ mice. Erythrocytes were depleted
with ACK lysis buffer, and contaminating platelets in the blood were removed
by an additional ficoll gradient. For adoptive transfer experiments, FACS-
sorted CD115+ckitCD11cCD11b+ Gr1+ or Gr1 monocytes from B6
CD45.1 mice were i.v. injected at 33 106 cells into colitic B6 CD45.2 Rag1/
mice that had received CD4+CD45RBhi T cells >6 weeks earlier. Thirty-six
hours after monocyte transfer, tissues were collected for the detection of
CD45.1+E-cadherin+ DCs by FACS analysis. For in vitro culture, FACS-sorted
Gr1+ or Gr1CD115+ monocytes were incubated overnight in RPMI supple-
mented with 10% FCS, 2 mM L-glutamine, and 100 U of penicillin and strep-
tomycin. GM-CSF (5% hybridoma supernatant) was added to some wells.
The cells were analyzed for expression of E-cadherin and CD11c.
Generation of BM-DCs
BM-DCs were prepared as previously described (Inaba et al., 1992b). Cells
were cultured in 6-well tissue culture plates (Costar) for 8 days in complete
medium supplemented with 5% GM-CSF. TGF-b (10 ng/ml, R&D systems)
was added to some wells from day 0. DCs were collected, incubated with
an anti-FcR antibody, and labeled with anti-mouse E-cadherin, CD11c and
7-AAD prior to FACS analysis or cell sorting.
Quantitation of Gene Expression Using Real-Time PCR
Total RNA was purified from sorted cells using RNAeasy kits (QIAGEN). cDNA
was synthesized using Superscript III reverse transcriptase and Oligo dT
primers (both from Invitrogen). Quantitative PCR reactions were performed
using either quantitect Primer Assays with SYBR green PCR mastermix
(QIAGEN) or the following reagents: IL-23 p19 primer AGCGGGACATATGAA
TCTACTAAGAGA, GTCCTAGTAGGGAGGTGTGAAGTTG, and FAM/TAMRA-
labeled probe CCAGTTCTGCTTGCAAAGGATCCGC; IL-12 p40 primers GAC
CATCACTGTCAAAGAGTTTCTAGAT, AGGAAAGTCTTGTTTTTGAAATTTTTT
AA, and FAM/TAMRA-labeled probe CCACTCACATCTGCTGCTCCACAAG
AAG; HPRT primers GACCGGTCCCGTCATGC, TCATAACCTGGTTCATC
ATCGC; and VIC/TAMRA-labeled probe ACCCGCAGTCCCAGCGTCGTC.
cDNA samples were assayed in triplicate using a Chromo4 detection system
(MJ Research), and gene-expression levels for each individual sample were
normalized to HPRT. Mean relative gene expression was determined, and
differences were calculated using the 2DC(t) method (Pfaffl, 2001).
T Cell Differentiation Assay
Cell suspensions were prepared from the spleens of DO11.10-SCID
mice. CD4+ T cells were isolated by labeling with magnetic anti-CD4 beads
(Miltenyi Biotec) and separating the cell populations using LS MACS columns
(Miltenyi Biotec). The positively selected CD4+ T cells were labeled with 10 mM
CFDA-SE using a Vybrant CFDA-SE Cell Tracer Kit (Invitrogen). 23 105 T cells
were cultured together with 3 3 104 MLN E-cadherin+ or E-cadherin
CD11chiCD1037-AADCD4 cells, or MHC class II+CD11cF4/80+ cells, in
the presence or absence of 5mg/ml OVA protein in complete RPMI for
4 days. T cells were counted and stained for CD4, and T cell proliferation
was assessed by dilution of the CFSE dye using FACS analysis.
Adoptive Transfer of BM-DCs
BM-DCs were generated and sorted into E-cadherin+ and E-cadherin
CD11chi cell fractions. 3 3 106 BM-DC subsets were i.p. injected into B6
Rag1/ mice that had received CD4+CD45RBhi T cells 2 weeks earlier.
Ten days post-DC transfer, intestinal tissues were collected for histologic
analysis, and intracellular cytokine staining was performed on GALT cell
preparations.566 Immunity 32, 557–567, April 23, 2010 ª2010 Elsevier Inc.Statistics
An unpaired Student’s t test was performed in Prism (Graphpad) in all
cases. Where appropriate, mean ± SD is represented on graphs. *p < 0.05;
**p < 0.001; ***p < 0.001.SUPPLEMENTAL INFORMATION
The Supplemental Information includes five figures and can be found with this
article online at doi:10.1016/j.immuni.2010.03.017.
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